This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Miyatake, Y. Articles by Yoshiki, T. Search for Related Content PubMed PubMed Citation Articles by Miyatake, Y. Articles by Yoshiki, T.

(American Journal of Pathology. 2006;169:189-199.)
© 2006 American Society for Investigative Pathology
DOI: 10.2353/ajpath.2006.051225

Role of Neuronal Interferon- in the Development of Myelopathy in Rats Infected with Human T-Cell Leukemia Virus Type 1

From the Department of Pathology/Pathophysiology, Division of Pathophysiological Science, Hokkaido University Graduate School of Medicine, Sapporo, Japan

Human T-cell leukemia virus type 1 (HTLV-1) is the causative agent of not only adult T-cell leukemia but also HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). Among the rat strains infected with HTLV-1, chronic progressive myelopathy, named HAM rat disease, occurs exclusively in WKAH rats. In the present study, we found that HTLV-1 infection induces interferon (IFN)- production in the spinal cords of HAM-resistant strains but not in those of WKAH rats. Neurons were the major cells that produced IFN- in HTLV-1-infected, HAM-resistant strains. Administration of IFN- suppressed expression of pX, the gene critically involved in the onset of HAM rat disease, in an HTLV-1-immortalized rat T-cell line, indicating that IFN- protects against the development of HAM rat disease. The inability of WKAH spinal cord neurons to produce IFN- after infection appeared to stem from defects in signaling through the interleukin (IL)-12 receptor. Specifically, WKAH-derived spinal cord cells were unable to up-regulate the IL-12 receptor ß2 gene in response to IL-12 stimulation. We suggest that the failure of spinal cord neurons to produce IFN- through the IL-12 pathway is involved in the development of HAM rat disease.

This article has been cited by other articles:

				S. Kinpara, A. Hasegawa, A. Utsunomiya, H. Nishitsuji, H. Furukawa, T. Masuda, and M. Kannagi Stromal Cell-Mediated Suppression of Human T-Cell Leukemia Virus Type 1 Expression In Vitro and In Vivo by Type I Interferon J. Virol., May 15, 2009; 83(10): 5101 - 5108. [Abstract] [Full Text] [PDF]

				P. V. Afonso, S. Ozden, M.-C. Prevost, C. Schmitt, D. Seilhean, B. Weksler, P.-O. Couraud, A. Gessain, I. A. Romero, and P.-E. Ceccaldi Human Blood-Brain Barrier Disruption by Retroviral-Infected Lymphocytes: Role of Myosin Light Chain Kinase in Endothelial Tight-Junction Disorganization J. Immunol., August 15, 2007; 179(4): 2576 - 2583. [Abstract] [Full Text] [PDF]